Cargando…

Fetal biometry assessment with Intergrowth 21st’s and Salomon’s equations in rural Burkina Faso

BACKGROUND: Ultrasound scanning during the 2nd or the 3rd trimester of pregnancy for fetal size disturbances screening is heavily dependent of the choice of the reference chart. This study aimed to assess the agreement of Salomon and the Intergrowth 21st equations in evaluating fetal biometric measu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bihoun, Biébo, Zango, Serge Henri, Traoré-Coulibaly, Maminata, Valea, Innocent, Ravinetto, Raffaella, Van Geertruyden, Jean-Pierre, D’Alessandro, Umberto, Tinto, Halidou, Robert, Annie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449020/ https://www.ncbi.nlm.nih.gov/pubmed/32847549 http://dx.doi.org/10.1186/s12884-020-03183-5

Ejemplares similares

Age-modified factors associated with placental malaria in rural Burkina Faso
por: Bihoun, Biébo, et al.
Publicado: (2022)

Association of malaria and curable sexually transmitted infections with pregnancy outcomes in rural Burkina Faso
por: Zango, Serge Henri, et al.
Publicado: (2021)

Malaria and curable sexually transmitted infections in pregnant women: A two-years observational study in rural Burkina Faso
por: Zango, Serge Henri, et al.
Publicado: (2020)

Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Burkina Faso: an open label trial
por: Birgersson, Sofia, et al.
Publicado: (2020)

The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso
por: Tinto, Halidou, et al.
Publicado: (2014)

Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso
por: Tahita, Marc C, et al.
Publicado: (2015)

Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort study
por: Natama, Hamtandi Magloire, et al.
Publicado: (2018)

Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine–artesunate in a rural health district in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022)

Polymorphisme de Plasmodium falciparum et mutations des gènes de résistance Pfcrt et Pfmdr1 dans la zone de Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2021)

Prevalence and risk factors of malaria among first antenatal care attendees in rural Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2022)

Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2020)

High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2019)

Magnitude of low birthweight in malaria endemic settings of Nanoro, rural Burkina Faso: a secondary data analysis
por: Lingani, Moussa, et al.
Publicado: (2021)

Genetic variation in the immune system and malaria susceptibility in infants: a nested case–control study in Nanoro, Burkina Faso
por: Natama, Hamatandi Magloire, et al.
Publicado: (2021)

An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso
por: Valea, Innocent, et al.
Publicado: (2012)

Malaria and curable sexually transmitted and reproductive tract coinfection among pregnant women in rural Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2021)

Low birth weight and its associated risk factors in a rural health district of Burkina Faso: a cross sectional study
por: Lingani, Moussa, et al.
Publicado: (2022)

Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso
por: Natama, Hamtandi Magloire, et al.
Publicado: (2020)

Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2020)

Household costs associated with seeking malaria treatment during pregnancy: evidence from Burkina Faso and The Gambia
por: Duval, Laetitia, et al.
Publicado: (2022)

In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2020)

Gender differences in sociodemographic and behavioural factors associated with BMI in an adult population in rural Burkina Faso – an AWI-Gen sub-study
por: Boua, Romuald Palwende, et al.
Publicado: (2018)

Increase in the prevalence of mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso
por: Ruizendaal, Esmée, et al.
Publicado: (2017)

Safety Profile of Drug Use During Pregnancy at Peripheral Health Centres in Burkina Faso: A Prospective Observational Cohort Study
por: Rouamba, Toussaint, et al.
Publicado: (2018)

Assessment of a combined strategy of seasonal malaria chemoprevention and supplementation with vitamin A, zinc and Plumpy’Doz™ to prevent malaria and malnutrition in children under 5 years old in Burkina Faso: a randomized open-label trial (SMC-NUT)
por: Sondo, Paul, et al.
Publicado: (2021)

Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes
por: Valea, Innocent, et al.
Publicado: (2010)

Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial
por: Lingani, Moussa, et al.
Publicado: (2023)

Associations between prenatal malaria exposure, maternal antibodies at birth, and malaria susceptibility during the first year of life in Burkina Faso
por: Natama, Hamtandi Magloire, et al.
Publicado: (2023)

Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2016)

Could the Decision of Trial Participation Precede the Informed Consent Process? Evidence From Burkina Faso
por: Paré Toe, Lea, et al.
Publicado: (2013)

In Vivo Antiplasmodial Activity of Two Sahelian Plant Extracts on Plasmodium berghei ANKA Infected NMRI Mice
por: Bonkian, Léa Nadège, et al.
Publicado: (2018)

Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2015)

Malaria prevention measures in Burkina Faso: distribution and households expenditures
por: Yaya Bocoum, Fadima, et al.
Publicado: (2014)

Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study
por: Nambozi, Michael, et al.
Publicado: (2019)

Patterns of child mortality in rural area of Burkina Faso: evidence from the Nanoro health and demographic surveillance system (HDSS)
por: Noori, Navideh, et al.
Publicado: (2021)

Prostate cancer outcome in Burkina Faso
por: Kabore, Fasnéwindé A, et al.
Publicado: (2011)

Plasmodium falciparum gametocyte carriage in symptomatic patients shows significant association with genetically diverse infections, anaemia, and asexual stage density
por: Sondo, Paul, et al.
Publicado: (2021)

Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
por: Rouamba, Toussaint, et al.
Publicado: (2021)

Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial
por: Nambozi, Michael, et al.
Publicado: (2015)

Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change
por: Tinto, Halidou, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2q6puuds65el0arqu972n91o50